RUMORED BUZZ ON ACTIVE PHARMACEUTICAL INGREDIENT MANUFACTURERS

associated machine failures since neither physicians nor individuals have all of the information necessary to make adequate judgments of merchandise quality and legal tort cures are gradual, inefficient, and extremely expensive. The modifications into the CGMP regulation will require manufacturers to extend [Page 52644] their high quality programs